Delivery Order SPE2DB22D6029-SPE2DB25FLUEN
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.80, is for the delivery of 160 mg/16 mL vials of the drug Docetaxel, a chemotherapy medication. This contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $14,738.74, is for the supply of Docetaxel 160 mg/16 ml vials. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,975,167 units of Docetaxel 80 mg/4 ml vial 4 ml, a specialty medication. The contract has a firm fixed price of $1,317.74 and a completion date of January 21, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is for the delivery of 160 mg/16 ml vials of the drug Docetaxel. The award, valued at $8,805.11, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 15, 2024. There is no set-aside designation for this award. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,402.12 firm fixed-price delivery order is for the supply of 80 mg/4 ml vials of the chemotherapy drug docetaxel. The contract has an ultimate completion date of October 13, 2022 and was awarded on October 12, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOCETAXEL 80 MG/8 ML VIAL 8ML. The total potential value of this order is $1,958.40, with a completion date of February 20, 2024. This order is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential...
The Defense Logistics Agency awarded a $54,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 8 milliliter vials of docetaxel, a chemotherapy drug, under National Stock Number 6505-01-594-4661. Performance will take place in Conshohocken, Pennsylvania from July 14-17, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the chemotherapy medication to the Defense Logistics Agency without use of subcontractors on this order. The...
The Defense Logistics Agency awarded a $3,761.82 delivery order to Amerisourcebergen Drug Corp for the supply of 4562082718, described as DOCETAXEL 80 MG/8 ML VIAL 8ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania under firm fixed pricing within the period of performance of September 7-8, 2023. The parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $149,340 to Amerisourcebergen Drug Corporation to supply docetaxel, an oncology drug, for one day's performance in Conshohocken, Pennsylvania. As a prime contractor on the Defense Logistics Agency's Prime Vendor program, which covers pharmaceuticals and other medical commodities for the Department of Defense, Amerisourcebergen will deliver the chemotherapy medication from its distribution center to support DOD...
This is a $31,094.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and was not set aside for any specific business category. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...